Gene · 3425
Papers1,870
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,870
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Generation and Characterization of Iduronidase-Cleavable ADCs. | Bioconjug Chem | 2023 | 38054705 | PubTator, text mining | PubMed |
| Clinical and genetic analysis of two patients with primary ciliary dyskinesia caused by a novel variant of DNAAF2. | BMC Pediatr | 2023 | 38053031 | PubTator, text mining | PubMed |
| [The development of selective XPO1 inhibitors in the treatment of acute myeloid leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 38049328 | PubTator, text mining | PubMed |
| Treatment of Parkinson's disease with biologics that penetrate the blood-brain barrier via receptor-mediated transport. | Front Aging Neurosci | 2023 | 38035276 | PubTator, text mining | PubMed |
| Tagged IDS causes efficient and engraftment-independent prevention of brain pathology during lentiviral gene therapy for Mucopolysaccharidosis type II. | Mol Ther Methods Clin Dev | 2023 | 38033460 | PubTator, text mining | PubMed |
| Brain-targeted ex vivo lentiviral gene therapy: Implications for MPS and beyond. | Mol Ther Methods Clin Dev | 2023 | 38027070 | PubTator, text mining | PubMed |
| Clinical Characteristics and Immune Responses in Children with Primary Ciliary Dyskinesia during Pneumonia Episodes: A Case-Control Study. | Children (Basel) | 2023 | 38002818 | PubTator, text mining | PubMed |
| Standardization of Molecular MRD Levels in AML Using an Integral Vector Bearing ABL and the Mutation of Interest. | Cancers (Basel) | 2023 | 38001621 | PubTator, text mining | PubMed |
| Predicting Thalassemia Using Feature Selection Techniques: A Comparative Analysis. | Diagnostics (Basel) | 2023 | 37998577 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing of 24 Spanish Families: Candidate Genes for Non-Syndromic Pediatric Keratoconus. | Genes (Basel) | 2023 | 37895187 | PubTator, text mining | PubMed |
| Recent Advances in In Vivo Somatic Cell Gene Modification in Newborn Pups. | Int J Mol Sci | 2023 | 37894981 | PubTator, text mining | PubMed |
| Clinical and Genetic Characterization of Patients with Primary Ciliary Dyskinesia in Southwest Saudi Arabia: A Cross Sectional Study. | Children (Basel) | 2023 | 37892347 | PubTator, text mining | PubMed |
| Safety outcomes and patients' preferences for home-based intravenous enzyme replacement therapy (ERT) in pompe disease and mucopolysaccharidosis type I (MPS I) disorder: COVID-19 and beyond. | Orphanet J Rare Dis | 2023 | 37891668 | PubTator, text mining | PubMed |
| 2023 APHL/ISNS Newborn Screening Symposium. | Int J Neonatal Screen | 2023 | 37873845 | PubTator, text mining | PubMed |
| Utilizing AAV-mediated LEAPER 2.0 for programmable RNA editing in non-human primates and nonsense mutation correction in humanized Hurler syndrome mice. | Genome Biol | 2023 | 37872590 | PubTator, text mining | PubMed |
| Expanding causal genes for Parkinson's disease via multi-omics analysis. | NPJ Parkinsons Dis | 2023 | 37865667 | PubTator, text mining | PubMed |
| Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinoma. | J Transl Med | 2023 | 37848935 | PubTator, text mining | PubMed |
| Zellweger's Syndrome With PEX6 Gene Mutation in Mixteco Neonates Due to Possible Founder Effect. | Cureus | 2023 | 37842507 | PubTator, text mining | PubMed |
| Chatbot-supported psychoeducation in adult attention-deficit hyperactivity disorder: randomised controlled trial. | BJPsych Open | 2023 | 37827996 | PubTator, text mining | PubMed |
| Innate Immune Response to Viral Vectors in Gene Therapy. | Viruses | 2023 | 37766208 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3425/papers?page=8